This company listing is no longer active
Jeisys Medical Past Earnings Performance
Past criteria checks 3/6
Jeisys Medical has been growing earnings at an average annual rate of 35.9%, while the Medical Equipment industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 29.1% per year. Jeisys Medical's return on equity is 25.2%, and it has net margins of 16.7%.
Key information
35.9%
Earnings growth rate
32.3%
EPS growth rate
Medical Equipment Industry Growth | 22.7% |
Revenue growth rate | 29.1% |
Return on equity | 25.2% |
Net Margin | 16.7% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 31% Price Jump
May 25Is There An Opportunity With Jeisys Medical Inc.'s (KOSDAQ:287410) 46% Undervaluation?
May 21The Returns On Capital At Jeisys Medical (KOSDAQ:287410) Don't Inspire Confidence
Apr 27Jeisys Medical Inc. (KOSDAQ:287410) Looks Just Right With A 28% Price Jump
Apr 09Revenue & Expenses Breakdown
How Jeisys Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 167,823 | 27,969 | 71,186 | 3,392 |
31 Mar 24 | 157,881 | 25,045 | 65,252 | 3,049 |
31 Dec 23 | 143,030 | 24,800 | 55,671 | 2,748 |
30 Sep 23 | 135,176 | 26,795 | 49,705 | 2,849 |
30 Jun 23 | 124,711 | 26,057 | 45,214 | 2,663 |
31 Mar 23 | 120,320 | 27,260 | 42,281 | 2,796 |
31 Dec 22 | 116,550 | 27,130 | 40,066 | 2,507 |
30 Sep 22 | 109,141 | 29,212 | 36,938 | 2,726 |
30 Jun 22 | 100,904 | 28,379 | 33,348 | 2,665 |
31 Mar 22 | 89,372 | 26,445 | 29,539 | 2,298 |
31 Dec 21 | 81,296 | 13,860 | 28,223 | 2,193 |
30 Sep 21 | 69,247 | 6,907 | 25,946 | 1,606 |
30 Jun 21 | 64,028 | 6,778 | 22,552 | 1,463 |
31 Mar 21 | 53,426 | -1,318 | 21,660 | 1,210 |
31 Dec 20 | 47,829 | 7,151 | 19,490 | 1,134 |
Quality Earnings: A287410 has a high level of non-cash earnings.
Growing Profit Margin: A287410's current net profit margins (16.7%) are lower than last year (20.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A287410's earnings have grown significantly by 35.9% per year over the past 5 years.
Accelerating Growth: A287410's earnings growth over the past year (7.3%) is below its 5-year average (35.9% per year).
Earnings vs Industry: A287410 earnings growth over the past year (7.3%) exceeded the Medical Equipment industry 4%.
Return on Equity
High ROE: A287410's Return on Equity (25.2%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/11/08 11:33 |
End of Day Share Price | 2024/10/18 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jeisys Medical Inc. is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Sae-rom Lee | Daishin Securities Co. Ltd. |
Jonghyun Park | DAOL Investment & Securities Co., Ltd. |
Sangsoo Kim | Goldman Sachs |